A retrospective study to assess real-world treatment patterns and outcomes in luspatercept-treated patients with myelofibrosis-associated anemia who required red blood cell transfusion in the United States

Authors

Shalon Jones
Yeran Li (ORCID: https://orcid.org/0000-0002-9777-7152)
Fabián Sanabria (ORCID: https://orcid.org/0000-0003-1279-2810)
Gabriela Hobbs (ORCID: https://orcid.org/0000-0002-0199-9333)
Ying Liu (ORCID: https://orcid.org/0000-0003-0214-6479)

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Shalon Jones, Yeran Li, Fabián Sanabria, Gabriela Hobbs et al.

Nov 3, 2025

Blood

Myeloproliferative Neoplasms: Diagnosis and Treatment

article

Shalon Jones, Yeran Li, Fabián Sanabria, Gabriela Hobbs, Ying Liu

November 3, 2025article en

No abstract available for this paper.

BloodVol. 146(Supplement 1)

Massachusetts General Hospital (US), Bristol-Myers Squibb (Sweden) (SE), Bristol-Myers Squibb (Switzerland) (CH)

Openalex Percentile: Top 44%

Myeloproliferative Neoplasms: Diagnosis and Treatment

AI Navigator

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.